Aducanumab

Tax included
Aducanumab (BIIB037), a human monoclonal antibody selective for aggregated forms of amyloid beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research.
MedChemExpress 
HY-P9967

Data sheet

Size
Multiple sizes
Reactivity
Amyloid-β
Application
Neuroscience-Neurodegeneration
CAS
1384260-65-4